Cannabis Patents For Pancreatic And Breast Cancers To Get A Review, CBIH Works On Treatment For Other Serious Conditions
As rates of pancreatic and breast cancer increase among the population, Cannabis Bioscience International Holdings (OTCMKTS: CBIH) opted to address the infamous trend with new treatment methodologies. The Houston-based company submitted its inaugural pair of patents, targeting those with breast and pancreatic cancers, for legal review and subsequent registration."Given the stark statistics associated with these cancers, our team recognizes the critical need for aggressive yet targeted interventions," Jennifer Salguero, PhD in Science with emphasis on Microbiology, said."We aim to not only target the tumors but also safeguard surrounding tissues, leveraging the inherent antitumor properties of cannabinoids."
